Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P.

Science. 1998 Aug 7;281(5378):838-42.

2.

Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.

Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1856-60.

3.

Bidirectional regulation of DARPP-32 phosphorylation by dopamine.

Nishi A, Snyder GL, Greengard P.

J Neurosci. 1997 Nov 1;17(21):8147-55.

5.

Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.

Edwards S, Simmons DL, Galindo DG, Doherty JM, Scott AM, Hughes PD, Wilcox RE.

Alcohol Clin Exp Res. 2002 Feb;26(2):173-80.

PMID:
11964556
6.

Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.

Nishi A, Bibb JA, Matsuyama S, Hamada M, Higashi H, Nairn AC, Greengard P.

J Neurochem. 2002 May;81(4):832-41.

7.

Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.

Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G.

Neuroscience. 1998 May;84(1):223-8.

PMID:
9522376
8.

Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.

Dunah AW, Sirianni AC, Fienberg AA, Bastia E, Schwarzschild MA, Standaert DG.

Mol Pharmacol. 2004 Jan;65(1):121-9.

9.

Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum.

Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JC, Stipanovich A, Caboche J, Lombroso PJ, Nairn AC, Greengard P, Hervé D, Girault JA.

Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):491-6. Epub 2004 Dec 17.

10.

Amplification of dopaminergic signaling by a positive feedback loop.

Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, Greengard P.

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12840-5.

11.

[Role of DARPP-32 in dopamine signal transduction in the striatum].

Nishi A.

Tanpakushitsu Kakusan Koso. 1998 Dec;43(15):2172-81. Review. Japanese. No abstract available.

PMID:
9868353
12.

D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.

Flores-Hernandez J, Hernandez S, Snyder GL, Yan Z, Fienberg AA, Moss SJ, Greengard P, Surmeier DJ.

J Neurophysiol. 2000 May;83(5):2996-3004.

13.

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.

Flores-Hernández J, Cepeda C, Hernández-Echeagaray E, Calvert CR, Jokel ES, Fienberg AA, Greengard P, Levine MS.

J Neurophysiol. 2002 Dec;88(6):3010-20.

14.

Regulation of spinophilin Ser94 phosphorylation in neostriatal neurons involves both DARPP-32-dependent and independent pathways.

Uematsu K, Futter M, Hsieh-Wilson LC, Higashi H, Maeda H, Nairn AC, Greengard P, Nishi A.

J Neurochem. 2005 Dec;95(6):1642-52. Epub 2005 Nov 21.

15.

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.

Halpain S, Girault JA, Greengard P.

Nature. 1990 Jan 25;343(6256):369-72.

PMID:
2153935
16.

Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32.

Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, Greengard P, Fredholm BB.

J Neurochem. 2000 Jul;75(1):248-57.

17.

Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1.

Zachariou V, Benoit-Marand M, Allen PB, Ingrassia P, Fienberg AA, Gonon F, Greengard P, Picciotto MR.

Biol Psychiatry. 2002 Apr 15;51(8):612-20.

PMID:
11955461
18.

Diverse psychotomimetics act through a common signaling pathway.

Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P.

Science. 2003 Nov 21;302(5649):1412-5.

19.

Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum.

Chergui K, Svenningsson P, Greengard P.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2191-6. Epub 2004 Feb 9.

20.

DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens.

Maldve RE, Zhang TA, Ferrani-Kile K, Schreiber SS, Lippmann MJ, Snyder GL, Fienberg AA, Leslie SW, Gonzales RA, Morrisett RA.

Nat Neurosci. 2002 Jul;5(7):641-8.

PMID:
12068305

Supplemental Content

Support Center